Generalized lipodystrophy

GL · Rare Disease · 1 drugs · 1 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
MibavademabREGNLEPR agonist (monoclonal antibody)Monoclonal antibodySCPHASE3
Indications (1)
Generalized lipodystrophy
Mibavademab PHASE3
Data from Supabase · Updated 2026-03-24